Management of Blood Pressure by Trivrit and Aragvadha Churna as daily mild laxative
- Conditions
- Essential (primary) hypertension,
- Registration Number
- CTRI/2019/11/022040
- Lead Sponsor
- Dr Manju Mohan
- Brief Summary
Patients will be recruited from inclusion criteria and study the effect of Trivrit and Aragvadha Churna Nitya virechana in Stage 1 Essential Hypertension
To study the effect of Nitya virechana with Trivrit Churna on systolic and diastolic blood pressure.
To study the effect of Nitya virechana with Aragvadha Churna on systolic and diastolic blood pressure
To compare the effect of Nitya virechana with Trivrit and Aragvadha churna on systolic and diastolic blood pressure.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 30
- 1.Patients of either sex between the age group of 30-60 yrs will be selected.
- 2.Newly detected cases of Stage 1 Essential Hypertension will be selected.
1.Hypertension associated with: a.Cardio-vascular diseases b.Cerebro-vascular diseases c.Hypothyroidism d.Diabetes Mellitus (Type 1/ Type 2/ GDM) e.Pregnant and lactating women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduce in the symptoms and range of Blood pressure Six months
- Secondary Outcome Measures
Name Time Method 1.To study the effect of Nitya Virechana with Trivrit Churna on Systolic and Diastolic blood pressure. 2.To study the effect of Nitya Virechana with Aragvadha Churna on Systolic and Diastolic blood pressure.
Trial Locations
- Locations (1)
Mahatma Gandhi Ayurved College Hospital and Research Center Salod (H) Wardha
🇮🇳Wardha, MAHARASHTRA, India
Mahatma Gandhi Ayurved College Hospital and Research Center Salod (H) Wardha🇮🇳Wardha, MAHARASHTRA, IndiaDr Manju MohanPrincipal investigatormanjumohan13@gmail.com